Conversely, hospitalized COVID-19 patients > 70 years of age showed increased blood plasmablast B cells (CD19low, CD20-, IgD-, IgM-, CD80+, CD38+), compared to hospitalized COVID-19 patients < 60 years of age [95]. This evidence concerns the gene CD38 and COVID-19.